“ Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers ”, Braz. J. Pharm. Sci., vol. 51, no. 1, pp. 203–211, Mar. 2015, doi: 10.1590/S1984-82502015000100020.